Primary and Secondary Prevention of Lung Cancer: Tobacco Treatment

Hasmeena Kathuria; Enid Neptune

doi:10.1016/j.ccm.2019.10.002

Primary and Secondary Prevention of Lung Cancer: Tobacco Treatment

Clin Chest Med. 2020 Mar;41(1):39-51. doi: 10.1016/j.ccm.2019.10.002.

Authors

Hasmeena Kathuria¹, Enid Neptune²

Affiliations

¹ The Pulmonary Center, Boston University Medical Center, Boston University, 72 East Concord Street R304, Boston, MA 02118, USA.
² Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins School of Medicine, 1830 East Monument Street, Room 549, Baltimore, MD 21287, USA. Electronic address: eneptune@jhmi.edu.

PMID: 32008628
DOI: 10.1016/j.ccm.2019.10.002

Abstract

Tobacco dependence is the most consequential target to reduce the burden of lung cancer worldwide. Quitting after a cancer diagnosis can improve cancer prognosis, overall health, and quality of life. Several oncology professional organizations have issued guidelines stressing the importance of tobacco treatment for patients with cancer. Providing tobacco treatment in the context of lung cancer screening is another opportunity to further reduce death from lung cancer. In this review, the authors describe the current state of tobacco dependence treatment focusing on new paradigms and approaches and their particular relevance for persons at risk or on treatment for lung cancer.

Keywords: Lung cancer screening; Lung cancer stigma; Nicotine addiction; Opt-out approaches; Teachable moment; Tobacco dependence treatment.

Publication types

Review

MeSH terms

Humans
Lung Neoplasms / diagnosis
Lung Neoplasms / prevention & control*
Primary Prevention / methods*
Secondary Prevention / methods*
Smoking Cessation / methods*